Country Trust Bank Sells 105 Shares of Laboratory Corporation of America Holdings (NYSE:LH)

Country Trust Bank decreased its stake in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 0.1% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 154,408 shares of the medical research company’s stock after selling 105 shares during the period. Country Trust Bank owned about 0.15% of Laboratory Corporation of America Holdings worth $23,800,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Parallel Advisors LLC boosted its stake in shares of Laboratory Corporation of America Holdings by 377.7% in the first quarter. Parallel Advisors LLC now owns 1,261 shares of the medical research company’s stock valued at $177,000 after buying an additional 997 shares during the last quarter. Indiana Trust & Investment Management CO purchased a new stake in shares of Laboratory Corporation of America Holdings during the first quarter valued at approximately $202,000. Ingalls & Snyder LLC purchased a new stake in shares of Laboratory Corporation of America Holdings during the first quarter valued at approximately $206,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of Laboratory Corporation of America Holdings during the first quarter valued at approximately $208,000. Finally, TNB Financial purchased a new stake in shares of Laboratory Corporation of America Holdings during the second quarter valued at approximately $208,000. 91.89% of the stock is currently owned by institutional investors.

Laboratory Corporation of America Holdings (NYSE LH) traded down 0.12% on Friday, reaching $156.21. The company’s stock had a trading volume of 441,945 shares. Laboratory Corporation of America Holdings has a 12 month low of $119.51 and a 12 month high of $164.22. The company has a 50-day moving average price of $155.18 and a 200 day moving average price of $144.10. The company has a market cap of $15.90 billion, a P/E ratio of 21.88 and a beta of 0.94.

Laboratory Corporation of America Holdings (NYSE:LH) last issued its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.40 by $0.07. Laboratory Corporation of America Holdings had a return on equity of 16.85% and a net margin of 7.57%. The firm had revenue of $2.50 billion for the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the firm posted $2.36 EPS. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. On average, equities research analysts anticipate that Laboratory Corporation of America Holdings will post $9.51 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Country Trust Bank Sells 105 Shares of Laboratory Corporation of America Holdings (NYSE:LH)” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.com-unik.info/2017/08/11/country-trust-bank-sells-105-shares-of-laboratory-corporation-of-america-holdings-nyselh-updated.html.

LH has been the subject of a number of recent analyst reports. Morgan Stanley upped their target price on Laboratory Corporation of America Holdings from $154.00 to $166.00 and gave the stock an “overweight” rating in a research report on Thursday. Barclays PLC upped their target price on Laboratory Corporation of America Holdings from $182.00 to $183.00 and gave the stock an “overweight” rating in a research report on Thursday, July 27th. Zacks Investment Research raised Laboratory Corporation of America Holdings from a “sell” rating to a “hold” rating in a research report on Thursday, July 27th. Craig Hallum reaffirmed a “buy” rating and set a $179.00 target price (up previously from $157.00) on shares of Laboratory Corporation of America Holdings in a research report on Thursday, July 27th. Finally, Credit Suisse Group cut Laboratory Corporation of America Holdings to a “hold” rating and set a $146.00 target price for the company. in a research report on Thursday, July 13th. They noted that the move was a valuation call. Seven research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $159.00.

In other news, CFO Glenn A. Eisenberg sold 5,968 shares of the business’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $159.46, for a total value of $951,657.28. Following the sale, the chief financial officer now directly owns 18,122 shares of the company’s stock, valued at approximately $2,889,734.12. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Lisa J. Uthgenannt sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $160.00, for a total transaction of $800,000.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 14,581 shares of company stock worth $2,256,899. Insiders own 0.90% of the company’s stock.

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

What are top analysts saying about Laboratory Corporation of America Holdings? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Laboratory Corporation of America Holdings and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit